|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
On another record day for the major benchmarks, shares of Skechers skyrocketed on earnings and Celgene tumbled after discontinuing a drug trial.
Stocks that moved substantially or traded heavily Friday: Celgene Corp., down $14.63 to $121.33 The drugmaker ended late-stage testing of a potential treatment for Crohn's disease. General Electric Co., ...
Shares of athletic shoe maker Skechers Inc. zoomed more than 37% Friday, after the company blew past earnings estimates for the third quarter, prompting a round of stock price target increases from analysts ...
Nike and Under Armour have struggled mightily in recent months, with most of the blame going to their ailing sneaker businesses. Shares of sneaker retailers Finish Line and Foot Locker are down 45% and 56%, respectively. On Friday, the mid-size shoe company stunned Wall Street with a better-than-expected earnings report.
Skechers shares soared in premarket trading Friday after the company posted third-quarter earnings that blew past analysts' estimates on record sales.
Skechers (SKX) is rallying sharply on Friday, on a much better-than-expected earnings report. For the third quarter, Skechers said it earned 59 cents a share on revenue that rose 16.2% year over year to $1.09 billion. Analysts were looking for earnings per share of just 44 cents, on revenue of $1.07 billion.
Honeywell, PayPal, Skechers and Chipotle are among the stocks to watch.